• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
      • Open API
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • TRANSCAN
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol-South Tyrol-Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
        • AI Mission Austria
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

How safe are environmental chemicals

Daniela Schuster (ORCID: 0000-0002-9933-8938)
  • Grant DOI 10.55776/P26782
  • Funding program Principal Investigator Projects
  • Status ended
  • Start May 1, 2014
  • End April 30, 2019
  • Funding amount € 307,576
  • Project website

Disciplines

Computer Sciences (65%); Medical-Theoretical Sciences, Pharmacy (35%)

Keywords

  • In Silico Screening,
  • Toxicology Predictions,
  • Environmental Chemicals,
  • Mechanism-Based Toxicity
Abstract Final report

We are directly exposed to a variety of diverse synthetic chemicals on a daily basis, for example when using cleaning products, cosmetics, drugs, plastics, and food additives. Many of these chemicals, e.g. environmental phenols, phthalates, and herbicides, can be detected in human blood or urine samples. Accordingly, due to the constant exposure to chemicals, it is essential to evaluate potential hazards and health risks. Within the EUs REACH program and the US National Toxicity Program, chemicals are studied for their potential endocrine disrupting effects. At the same time, alternatives to in vivo testing in the form of in silico / in vitro testing are evaluated. In silico predictions are highly useful to prioritize chemicals for in vitro / in vivo testing. Pharmacophore models are excellent in silico screening tools to select potentially active compounds from large chemical databases. However, so far they have hardly been used to suggest chemicals for toxicity evaluations. In the proposed project, a pharmacophore-based in silico screening platform will be developed to prioritize chemicals for mechanism-based toxicity evaluations. This platform will focus on 14 steroid- synthesizing and -metabolizing enzymes, which have not been considered in systematic toxicity studies so far. For each target, models will be experimentally validated to optimize their predictive power. Environmental chemical databases will be screened for potentially active compounds. Among the virtual hits, chemicals with direct consumer exposure or high annual production volume will be acquired and tested in vitro. Identified active chemical classes will be further investigated by testing structurally related compounds in the in vitro assays. Based on all experimental results, the pharmacophore models will be optimized to correctly separate active from inactive chemicals on the respective targets. For the studied chemical classes, structure-activity-relationship models will be built to further optimize the predictions within the respective compound class. The developed model collection and exemplified case studies will lay ground for future, systematic safety evaluations of chemicals. In the future, such in silico platforms combined with in vitro testing are expected to form one basis for toxicity predictions.

Safety of environmental chemicals The project "safety of environmental chemicals" aimed to identify chemicals, which may interfere with hormone homeostasis in the human body. For this, we aimed to establish computational models as pre-filters to focus time- and cost-intensive wet lab work on the most suspicious chemicals. We focused our investigations on industrial chemicals with high production volume in the EU, food contact materials, food additives such as conserving agents, substances used in cosmetic products, drugs and natural compounds, which are also used as food supplements. It is well known that chemicals can act like hormones themselves. However, the impact of chemicals on the biosynthesis and degradation of hormones has not been investigated that well. Synthesis and degradation, together called metabolism, are mediated by specific enzymes, which regulate the balance between active and inactive hormones in cells. The focus of this project lied on the potential inhibition of these enzymes by environmental chemicals. We developed a multi-step protocol for the selection of chemicals to test. First, we developed computational models for enzyme inhibition for essential enzyme involved in sex hormone biosynthesis. These models were extensively theoretically validated by classification experiments of known active and inactive compounds. Only models that passed these tests were further used in the project. Second, we selected chemicals with unknown effects on the enzymes for biological testing and evaluated, if the models could correctly predict the actual activity in vitro. Successful models were then employed predict potentially active compounds from environmental chemical databases. However, the main aim of this project was the development of high quality computational models, not (yet) their broad application to environmental chemicals - this will be scope of future projects. In the course of our proof of principle experiments, we could already identify several enzyme inhibitors among widely used chemicals. For example, parabens were discovered as a class of compounds inhibiting estrogen degradation. High intracellular estrogen levels may lead to adverse effects especially during sensitive phases in life just like pregnancy and puberty. They may promote feminization. However, parabens are degraded rapidly in the human body and the relevance of our finding must be evaluated by further experiments. The same is true for another chemical inhibiting estrogen degradation, ethyl vanillate, which is a flavoring agent sometimes used in chewing gum. Further examples include itraconazole and posaconazole, which can interfere with glucocorticoid balance. Especially during pregnancy, an excess of glucocorticoids can lead to disturbed development of the fetus. Finally, we identified epoxiconazole, an antifungal chemical used in agriculture, as inhibitor of cholesterol and aldosterone synthesis. This inhibition could influence the immune system and blood pressure regulation and needs follow-up studies to evaluate effects in vivo.

Research institution(s)
  • Paracelsus Medizinische Privatuniversität Salzburg - Privatstiftung - 86%
  • Universität Innsbruck - 14%
Project participants
  • Barbara Matuszczak, Universität Innsbruck , associated research partner
International project participants
  • Klaus Schleifer, BASF Ludwigshafen - Germany
  • Jerzy Adamski, Helmholtz Zentrum München - Germany
  • Johannes Kirchmair, Universität Hamburg - Germany
  • Rolf Wolfgang Hartmann, Universität des Saarlandes - Germany
  • Alex Odermatt, Universität Basel - Switzerland
  • Paul Foster, The University of Birmingham

Research Output

  • 466 Citations
  • 32 Publications
  • 2 Scientific Awards
  • 3 Fundings
Publications
  • 2015
    Title Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
    DOI 10.3390/molecules201219880
    Type Journal Article
    Author Kaserer T
    Journal Molecules
    Pages 22799-22832
    Link Publication
  • 2015
    Title Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2
    DOI 10.1016/j.ejmech.2015.04.017
    Type Journal Article
    Author Kaserer T
    Journal European Journal of Medicinal Chemistry
    Pages 445-457
    Link Publication
  • 2015
    Title In Silico Predictions of Drug – Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition – a Comparative Study of Virtual Screening Performance
    DOI 10.1002/minf.201400192
    Type Journal Article
    Author Kaserer T
    Journal Molecular Informatics
    Pages 431-457
  • 2015
    Title Pharmacophore models and pharmacophore-based virtual screening; In: In Silico Drug Discovery and Design: Theory, Methods, Challenges and Applications
    Type Book Chapter
    Author Akram M
    Publisher CRC Press
    Pages 123-153
  • 2015
    Title Modeling modulators of steroid hormone actions: receptor ligands and biotransformation inhibitors
    Type Other
    Author Vuorinen Ae
  • 2015
    Title Establishing an optimized in silico workflow for activity profiling
    Type Other
    Author Kaserer T
  • 2015
    Title Computer-aided discovery of novel 17-hydroxysteroid dehydrogenase type 4 (17-HSD4) inhibitors
    Type Conference Proceeding Abstract
    Author Kaserer T
    Conference 3rd Congress on Steroid Research, 5.-18.11.2015; Chicago, USA
  • 2015
    Title Pharmacophore Modeling and virtual screening to discover cytochrome P450 17 inhibitors among environmental chemicals
    Type Conference Proceeding Abstract
    Author Akram M
    Conference 29th Molecular Modeling Workshop; 09.-11.03.2015; Erlangen, Germany
  • 2015
    Title Molecular modeling of cytochrome P450 17 inhibitors for predicting the toxic effects of environmental chemicals
    Type Conference Proceeding Abstract
    Author Akram M
    Conference MCBO Science Day & 7th Life Science Day; 27.02.2015; Innsbruck, Austria
  • 2015
    Title Pharmacophore model-based identification of environmental chemicals inhibiting hydroxysteroid dehydrogenases
    Type Conference Proceeding Abstract
    Author Schuster D
    Conference 3rd Congress on Steroid Research; 15.-18.11.2015; Chicago, Illinois, USA
  • 2014
    Title Hydroxysteroid dehydrogenase inhibitors as potential endocrine disrupting agents
    Type Conference Proceeding Abstract
    Author Akram M
    Conference 6th Life Science Meeting; 24.-25.09.2014; Innsbruck
  • 2019
    Title Fingerprints and Pharmacophores; In: Fingerprints and pharmacophores
    Type Book Chapter
    Author Schuster D
    Publisher Elsevier
    Pages 619-627
  • 2019
    Title Identification of the fungicide epoxiconazole as inhibitor of human 11ß-hydroxylase and aldosterone synthase
    Type Conference Proceeding Abstract
    Author Akram M
    Conference 10. Paracelsus Science Get Together
  • 2019
    Title Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11ß-hydroxylase and aldosterone synthase
    Type Conference Proceeding Abstract
    Author Akram M
    Conference 26th Scientific Congress of the Austrian Pharmaceutical Society
  • 2018
    Title Pharmacophore Models for Toxicology Prediction; In: Computational Toxicology: Risk Assessment for Chemicals
    Type Book Chapter
    Author Schuster D
    Publisher John Wiley & Sons, Inc.
    Pages 121-144
  • 2018
    Title The anti-fungal epoxiconazole inhibits human CYP P450 11B1 and CYP P450 11B2: Virtual screening as a tool to find potential endocrine disruptors
    Type Conference Proceeding Abstract
    Author Akram M
    Conference Paracelsus Science Get Together 2018
  • 2018
    Title Development and validation of pharmacophore models for human cytochrome P450 11 B1 and P450 11B2 inhibition
    Type Conference Proceeding Abstract
    Author Akram M
    Conference Paracelsus Science Get Together 2018
  • 2017
    Title Three dimensional pharmacophore modeling and model validation of human CYP11B1 and CYP11B2 inhibition, potential targets for treating Cushing's syndrome and congestive heart failure
    Type Conference Proceeding Abstract
    Author Akram M
    Conference Pharma 2030 - Current and Future Challenges
  • 2017
    Title Docking of azole fungicides into human 11-HSD1, 11-HSD2 and murine 11-HSD2
    Type Conference Proceeding Abstract
    Author Beck Kr
    Conference Pharma 2030 - Current and Future Challenges
  • 2017
    Title Pharmacophore modeling and virtual screening for 17beta-hydroxysteroid dehydrogenase 7 inhibitors
    Type Other
    Author Fiala J
  • 2017
    Title Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors
    DOI 10.3389/fchem.2017.00104
    Type Journal Article
    Author Akram M
    Journal Frontiers in Chemistry
    Pages 104
    Link Publication
  • 2017
    Title Interference of Paraben Compounds with Estrogen Metabolism by Inhibition of 17ß-Hydroxysteroid Dehydrogenases
    DOI 10.3390/ijms18092007
    Type Journal Article
    Author Engeli R
    Journal International Journal of Molecular Sciences
    Pages 2007
    Link Publication
  • 2017
    Title Inhibition of 11ß-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole
    DOI 10.1016/j.bcp.2017.01.010
    Type Journal Article
    Author Beck K
    Journal Biochemical Pharmacology
    Pages 93-103
    Link Publication
  • 2019
    Title Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11ß-hydroxylase and aldosterone synthase
    DOI 10.1016/j.jsbmb.2019.04.007
    Type Journal Article
    Author Akram M
    Journal The Journal of Steroid Biochemistry and Molecular Biology
    Pages 105358
  • 2016
    Title Pharmacophore modeling and virtual screening for 3beta-hydroxysteroid dehydrogenase inhibitors
    Type Other
    Author Kurzemann F
  • 2016
    Title Construction of an industrial-chemical database including screening against anti-targets
    Type Other
    Author Lazic B
  • 2016
    Title Inhibition of 11 beta-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole
    Type Conference Proceeding Abstract
    Author Beck Kr
    Conference 52nd Congress of the European Societies of Toxicology (EUROTOX)
    Link Publication
  • 2016
    Title Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) ? partial agonists
    DOI 10.1016/j.ejmech.2016.07.072
    Type Journal Article
    Author Kaserer T
    Journal European Journal of Medicinal Chemistry
    Pages 49-62
    Link Publication
  • 2016
    Title Evaluation of tetrabromobisphenol A effects on human glucocorticoid and androgen receptors: A comparison of results from human- with yeast-based in vitro assays
    DOI 10.1016/j.tox.2016.09.014
    Type Journal Article
    Author Beck K
    Journal Toxicology
    Pages 70-77
    Link Publication
  • 2014
    Title Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17ß-Hydroxysteroid Dehydrogenase 2 Inhibitors
    DOI 10.1021/jm5004914
    Type Journal Article
    Author Vuorinen A
    Journal Journal of Medicinal Chemistry
    Pages 5995-6007
    Link Publication
  • 2017
    Title Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17ß-Hydroxysteroid Dehydrogenase Type 2
    DOI 10.1021/acs.jnatprod.6b00950
    Type Journal Article
    Author Vuorinen A
    Journal Journal of Natural Products
    Pages 965-974
    Link Publication
  • 2017
    Title Virtual screening applications in short-chain dehydrogenase/reductase research
    DOI 10.1016/j.jsbmb.2017.03.008
    Type Journal Article
    Author Beck K
    Journal The Journal of Steroid Biochemistry and Molecular Biology
    Pages 157-177
    Link Publication
Scientific Awards
  • 2017
    Title Speaker at the ALUMNI meeting at the Technical University of Dresden, Germany
    Type Personally asked as a key note speaker to a conference
    Level of Recognition Regional (any country)
  • 2015
    Title Invited speaker at the National Doctoral Program in Informational and Structural Biology (ISB) 2015 Winter School, Finland :Environmental chemicals disturbing hormone homeostasis: pharmacophore-based identification and examples
    Type Personally asked as a key note speaker to a conference
    Level of Recognition National (any country)
Fundings
  • 2016
    Title Erasmus+ fellowship to Muhammad Akram
    Type Fellowship
    Start of Funding 2016
    Funder Standortagentur Tirol
  • 2017
    Title Erasmus+ fellowship to Muhammad Akram
    Type Fellowship
    Start of Funding 2017
    Funder Standortagentur Tirol
  • 2016
    Title Ingeborg Hochmair Professorship (5 year full professorship salary sponsored by MedEl)
    Type Fellowship
    Start of Funding 2016
    Funder University of Innsbruck

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • IFG-Form
  • Acknowledgements
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF